Metformin hydrochloride
Metformax 1000 and Metformin Teva are different trade names for the same medicine.
Metformax 1000 contains metformin, a medicine used to treat diabetes. It belongs to a group of medicines called biguanides.
Insulin is a hormone produced by the pancreas that makes the body take in glucose (sugar) from the blood. The body uses glucose to produce energy or stores it for future use.
If the patient has diabetes, the pancreas does not produce enough insulin or the body cannot use the insulin it produces properly. This leads to high blood glucose levels. Metformax 1000 helps lower blood glucose levels to as close to normal as possible.
If the adult patient is overweight, long-term use of Metformax 1000 also helps reduce the risk of diabetes complications.
Taking metformin is associated with maintaining or slightly reducing body weight.
Metformax 1000 is used to treat patients with type 2 diabetes (also called "non-insulin-dependent diabetes") when diet and exercise alone have not been able to control blood glucose levels properly. It is used especially in patients who are overweight.
Adult patients can take Metformax 1000 alone or in combination with other oral anti-diabetic medicines (medicines taken orally or insulin).
Children aged 10 years or older and adolescents can take Metformax 1000 alone or in combination with insulin.
If any of the above applies to the patient, they should consult a doctor before taking this medicine.
Make sure the doctor has explained all doubts:
Before taking Metformax 1000, the patient should discuss it with their doctor or pharmacist .
Metformax 1000 may cause a very rare but very serious side effect called lactic acidosis, especially if the patient has kidney problems. The risk of lactic acidosis increases in cases of uncontrolled diabetes, severe infection, prolonged fasting or alcohol consumption, dehydration (see more information below), liver problems, and any conditions in which a part of the body is not adequately supplied with oxygen (e.g. acute severe heart disease).
If any of the above applies to the patient, they should consult their doctor for more detailed instructions.
a condition that may be associated with dehydration(significant water loss from the body),
such as severe vomiting, diarrhea, fever, exposure to high temperatures, or if the patient drinks less fluid than usual. The patient should consult their doctor for more detailed instructions.
of lactic acidosis, as this condition can lead to coma.
Symptoms of lactic acidosis include:
Lactic acidosis is a life-threatening condition that requires immediate hospital treatment.
If the patient is to undergo major surgery, they should not take Metformax 1000 during and for some time after the surgery. The doctor will decide when the patient should stop and resume treatment with Metformax 1000.
Metformax 1000 itself does not cause hypoglycemia (low blood glucose). However, if Metformax 1000 is taken with other anti-diabetic medicines that can cause hypoglycemia (such as sulfonylurea, insulin, meglitinides), there is a risk of hypoglycemia. If the patient experiences symptoms of hypoglycemia, such as fatigue, dizziness, increased sweating, rapid heartbeat, vision disturbances, or difficulty concentrating, eating or drinking something containing sugar usually helps.
During treatment with Metformax 1000, the doctor will check the patient's kidney function at least once a year or more often if the patient is elderly and/or has impaired kidney function.
If the patient is to be injected with a contrast agent containing iodine into the bloodstream, for example, for an X-ray examination or computed tomography, they should stop taking Metformax 1000 before or at the latest at the time of such injection. The doctor will decide when the patient should stop and resume treatment with Metformax 1000.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take. The patient may need more frequent blood glucose checks and kidney function tests or dose adjustments of Metformax 1000 by the doctor. It is especially important to inform about the following medicines:
The patient should avoid consuming excessive amounts of alcohol while taking Metformax 1000, as this may increase the risk of lactic acidosis (see "Warnings and precautions").
Metformax 1000 does not cause hypoglycemia (low blood glucose). This means that the medicine will not affect the patient's ability to drive or use machines. However, the patient should be careful when taking Metformax 1000 in combination with other anti-diabetic medicines that can cause hypoglycemia (such as sulfonylurea, insulin, meglitinides). Symptoms of hypoglycemia include fatigue, dizziness, increased sweating, rapid heartbeat, vision disturbances, or difficulty concentrating. The patient should not drive or use machines if they notice any of these symptoms.
This medicine should always be taken exactly as prescribed by the doctor or pharmacist. In case of doubts, the patient should consult their doctor or pharmacist.
Metformax 1000 will not replace the benefits of a healthy lifestyle. The patient should follow the doctor's advice on diet and exercise regularly.
Recommended dose:
Usually, the initial dose for children over 10 years old and adolescents is one 500 mg or 850 mg metformin hydrochloride tablet per day. The maximum dose of metformin is 2000 mg per day, given in 2 or 3 divided doses. Treatment of children aged 10 to 12 years is only recommended after special medical consultation, as the therapeutic experience in this age group is limited.
Usually, the initial dose for adults is one 500 mg or 850 mg metformin hydrochloride tablet, 2 or 3 times a day. The maximum dose of metformin is 3000 mg per day, given in 3 divided doses.
If the patient has impaired kidney function, the doctor may prescribe a lower dose.
If the patient is also taking insulin, the doctor will inform them how to start taking Metformax 1000.
Monitoring
How to take Metformax 1000
The patient should take the tablet during or after a meal. This will help avoid gastrointestinal side effects.
The patient should not crush or chew the tablets. They should swallow each tablet with a glass of water.
The dividing line on the tablet is only to facilitate breaking the tablet if the patient has difficulty swallowing it whole.
If, after some time, the patient thinks that the effect of Metformax 1000 is too strong or too weak, they should consult their doctor or pharmacist.
If the patient takes more Metformax 1000 than they should, they may experience lactic acidosis. Symptoms of lactic acidosis are non-specific and include vomiting, abdominal pain with muscle cramps, general feeling of being unwell, severe fatigue, and shortness of breath. Other symptoms include decreased body temperature and slowed heart rate. If the patient experiences any of these symptoms, they should immediately seek medical help, as lactic acidosis can lead to coma. The patient should stop taking Metformax 1000 and consult their doctor or go to the nearest hospital.
The patient should not take a double dose to make up for a missed dose. They should take the next dose at the usual time.
In case of doubts about taking this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Metformax 1000 can cause side effects, although not everybody gets them.
The following side effects are very serious and the patient should immediately consult their doctorif they experience any of these symptoms:
Very rare: may affect up to 1 in 10,000 people
Other side effects:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Very rare: may affect up to 1 in 10,000 people
Children and adolescents
Limited data in children and adolescents have shown that side effects were similar in nature and severity to those observed in adult patients.
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl .
Reporting side effects will help gather more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children. If Metformax 1000 is used in a child, the treatment should be supervised by parents or caregivers.
Do not use the medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
There are no special precautions for storing the medicine.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
White or almost white, oval tablet, with a dividing line, with the inscription "9/3" on one side and "72/14" on the other side.
Metformax 1000 is available in cardboard boxes containing 30, 60, 90, or 120 tablets.
For more detailed information, the patient should contact the marketing authorization holder or parallel importer.
Teva Pharma B.V.
Swensweg 5
2031GA Haarlem
Netherlands
Teva Pharmaceutical Works Private Limited Company
Pallagi út 13, 4042 Debrecen, Hungary
Merckle GmbH
Ludwig-Merckle-Strasse 3, 89143 Blaubeuren-Weiler, Germany
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Authorization number in Ireland, the country of export:PA0749/185/003
Metformine TEVA PHARMA 1000 mg, film-coated tablet
Metformin Teva
Metformin-ratiopharm 1.000 mg film-coated tablets
Metformin Teva
Adimet 1000 mg film-coated tablet
Metformax 1000
Metformina Teva
Date of leaflet approval: 28.02.2022
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.